These results confirm that PCK2 promotes the proliferation of ER+ breast cancer cells and suggest that PCK2 promotes glycolysis and mitochondrial oxidative phosphorylation in ER+ breast cancer cells. Here, ESR1 is linked to breast carcinoma.